SCHEMBL7587434

SCHEMBL7587434

O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)F)cc1Cl

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.88
MEN1 O00255 5/20 0.88
MAPT P10636 3/20 0.88
USP2 O75604 1/20 0.88
ALOX15 P16050 1/20 0.88
POLB P06746 1/20 0.51
ATM Q13315 1/20 0.47
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 2/20 0.40
TLR7 Q9NYK1 1/20 0.39
GAA P10253 2/20 0.39
THRB P10828 1/20 0.39
RECQL P46063 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TRPV1 Q8NER1 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PYGL P06737 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lufenuron SCHEMBL27105 0.94 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL29850969 0.94 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL29350147 0.94 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL4131569 0.94 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL15555900 0.94 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
Lufenuron SCHEMBL28709254 0.94 KMT2A (1.00) KMT2AMEN1MAPTUSP2ALOX15
SCHEMBL7591855 0.94 KMT2A (0.85) KMT2AMEN1MAPTUSP2ALOX15
SCHEMBL7585954 0.93 KMT2A (0.83) KMT2AMEN1MAPTUSP2ALOX15
SCHEMBL10934594 0.93 KMT2A (0.83) KMT2AMEN1MAPTUSP2ALOX15
SCHEMBL28933698 0.91 KMT2A (0.76) KMT2AMEN1MAPTUSP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0896532-B1 ACYL UREA COMPOUNDS FOR THE TREATMENT OF COCCIDIOIDOMYCOSIS IN WARM-BLOODED ANIMALS NOVARTIS AG (CH) 2002-10-02 EP claimed
EP-0896532-A1 ACYL UREA COMPOUNDS FOR THE TREATMENT OF COCCIDIOIDOMYCOSIS IN WARM-BLOODED ANIMALS Novartis AG (CH) 1999-02-17 EP claimed
US-5837734-A Method for the treatment of coccidioidomycosis in warm-blooded animals NOVARTIS CORPORATION (US) 1998-11-17 US claimed
WO-1997040826-A1 ACYL UREA COMPOUNDS FOR THE TREATMENT OF COCCIDIOIDOMYCOSIS IN WARM-BLOODED ANIMALS NOVARTIS AG (CH) 1997-11-06 WO claimed
US-5416102-A Administering orally, by injection or implantation, a dosage of flea growth inhibiting benzoyl urea compound CIBA-GEIGY CORPORATION (US) 1995-05-16 US claimed
US-5837734-A Method for the treatment of coccidioidomycosis in warm-blooded animals NOVARTIS CORPORATION (US) 1998-11-17 US disclosed
US-5416102-A Administering orally, by injection or implantation, a dosage of flea growth inhibiting benzoyl urea compound CIBA-GEIGY CORPORATION (US) 1995-05-16 US disclosed
US-4518804-A INTERMEDIATES FOR INSECTICDAL N-AROYL-N'-PHENYL UREAS THE DOW CHEMICAL COMPANY (US) 1985-05-21 US disclosed